Experimental drug reverses paralysis and vision loss in multiple sclerosis model
11 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
6 trends tracked about this subject — the full history, oldest to newest below.
11 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
15 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
Novartis shares climb following positive late-stage trial results for its experimental oral multiple sclerosis drug, Rhapsido.
Thousands of multiple sclerosis patients in England can now access the first drug approved to help improve walking.
Recent scientific studies reveal how the Epstein-Barr virus triggers immune responses tied to multiple sclerosis.
Biologists have identified how the Epstein-Barr virus triggers multiple sclerosis, opening new pathways for antiviral-based MS therapies.